KAM
PBYI icon

Kazazian Asset Management’s Puma Biotechnology PBYI Stock Holding History

Kazazian Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,962
Closed -$270K – 68
2019
Q1 		$270K Buy
+6,962
New +$213K 0.38% 45
2018
Q4 		– Sell
-15,035
Closed -$689K – 78
2018
Q3 		$689K Buy
15,035
+6,264
+71% +$302K 0.65% 38
2018
Q2 		$519K Buy
8,771
+1,614
+23% +$93.5K 0.48% 42
2018
Q1 		$487K Buy
7,157
+2,602
+57% +$195K 0.51% 46
2017
Q4 		$450K Buy
4,555
+472
+12% +$52.8K 0.46% 51
2017
Q3 		$489K Buy
4,083
+1,690
+71% +$157K 0.6% 37
2017
Q2 		$209K Buy
+2,393
New +$134K 0.32% 46

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return